I am in need of some assistance in Identifying a bacteria species. I am unable to locate a match in Bergey's Manual. Our copy is 20 years out of date. I know the photo isnt great, it was taken with a cell phone. The colonies are hot pink and were cultured on TSA slant. It is gram + micrococci, i... Read More
This image results from a project called "Initiation to microbiology investigation" accomplished by young students, where they collected a sample from a table surface and by inoculation they put it in CLED (cystine lactose electrolyte deficient) medium. Beautiful colonies of bacteria and fungu... Read More
The TWiP-lets reveal Balamuthia infection in the Children from Peru, and discuss resistance to pyrethroids uncovered by RNA sequencing of Anopheles mosquitoes.
Hosts: Read More
Groundbreaking research on the universality and diversity of microorganisms is now challenging the life sciences to upgrade fundamental theories that once seemed untouchable. To fully appreciate the change that... Read More
Vincent, Dickson, and Daniel discuss how filarial infection modulates the immune response to mycobacterial infection, and reveal a new case study.
Acid Fast stain done on a mix of Staphylococcus aureus and Mycobacterium smegmatis. The stain was done on a culture of M. smegmatis that was incubated on a TSA slant with 1ml TSB added at 37 degree's C for 4 days, S. aureus was incubated in TSB at 37 degree's C for 24 hrs. Several loops of eac... Read More
This article provides the preliminary results of a possible treatment/ Biological control agent for White Nose Syndrome (WNS) cause by Pseudogymnoascus destructans. It is estimated that over 5.5 of North American bats have died due to this deadly disease. Recently this method of treatment descri... Read More
Jessica Galloway-Peña, Ph.D., fellow in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center and her colleagues have shown that disruption of the microbiome by illness or the administration of therapeutics can often lea... Read More
This episode: Programming bacteria to sense and keep genomic records of environmental inputs!
(15.9 MB, 17.4 minutes)
In midsummer 1986, five years after starting my poliovirus laboratory at Columbia University, I received a letter from Frederick L. Schaffer, a virologist at the University of California, Berkeley, asking if I would like to have his collection of poliovirus stocks. He was retiring and the sample... Read More
The immune system is our biological defense shield. Antibodies protect the organism against invading pathogens such as viruses or bacteria. In the case of certain autoimmune diseases, however, this defense behavior is misdirected: The antibodies don't just target foreign substances; they also at... Read More
Toxoplasma gondii is estimated to chronically infect nearly one-third of the world's population, causing the condition Toxoplasmosis. It is most commonly associated with handling cat feaces and is a particular threat to pregnant women and immune-compromised individuals, such as HIV/AIDS patients... Read More
Dear Dr. Schaechter,
First off, I want to thank you for the effort you and your colleagues have invested in Small Things Considered and the podcast TWIM. Back when I had a longer commute to work, I listened more religiously than now, wh... Read More
This episode: Microbial predators in soil cause microbial prey to build fortifications!
(8.8 MB, 9.5 minutes)
DAKAR, Senegal - New Ebola cases were in the single digits another week, the World Health Organization said Wednesday, showing that contact tracing efforts are yielding results.
WASHINGTON (Sept. 11, 2015) - The O'Neill Institute for National and Global Health Law fall colloquium series continues Wednesday, Sept. 16 with a focus on Ebola. Read More
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to globa... Read More
A new type of cancer therapy based on seemingly unrelated elements of malaria and cancer is showing promise for development. Kairos Therapeutics, a Vancouver-based biotech company spun-out of The Centre for Drug Research and Development (CDRD), has partnered with VAR2 Pharmaceuticals to advance ... Read More